Jun. 25 at 5:52 PM
$BCTX just locked in a key commercialization partner — and it's already being used in Phase 3 🔥
BriaCell signed an MoU with Uneedle to support commercial-scale production of its proprietary microneedle technology for Bria-IMT, the company's lead Phase 3 candidate for metastatic breast cancer. 🚀
✅ Uneedle's device is already being used in BriaCell's ongoing pivotal Phase 3 study
✅ Collaboration focuses on regulatory and commercial readiness ahead of potential approval
See what Wall Street expects next 👉
https://www.zacks.com/stock/research/BCTX/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38544&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38544